Pacer Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 11,279,822 shares of IRWD stock, worth $38.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

11,279,822

Previous 8,907,639 26.63%

Holding current value

$38.8 Million

Previous $58.1 Million 20.17%

% of portfolio

0.11%

Previous 0.15%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.93 - $7.04 $9.32 Million - $16.7 Million	2,372,183 Added 26.63%	11,279,822 $46.4 Million
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $9.49 Million - $14.6 Million	1,701,452 Added 23.61%	8,907,639 $58.1 Million
Q1 2024 May 10, 2024	BUY	$8.32 - $15.45 $60 Million - $111 Million	7,206,187 New	7,206,187 $62.8 Million
Q2 2023 Jul 12, 2023	BUY	$10.1 - $11.6 $2.06 Million - $2.37 Million	204,428 Added 9.04%	2,466,228 $26.2 Million
Q1 2023 May 02, 2023	BUY	$10.37 - $12.56 $7.38 Million - $8.94 Million	711,756 Added 45.92%	2,261,800 $23.8 Million
Q4 2022 Feb 06, 2023	BUY	$9.9 - $12.43 $2.76 Million - $3.46 Million	278,591 Added 21.91%	1,550,044 $19.2 Million
Q3 2022 Oct 18, 2022	BUY	$10.14 - $12.38 $3.43 Million - $4.19 Million	338,287 Added 36.25%	1,271,453 $13.2 Million
Q2 2022 Aug 12, 2022	BUY	$11.05 - $12.72 $10.3 Million - $11.9 Million	933,166 New	933,166 $10.8 Million
Q2 2021 Jul 21, 2021	SELL	$10.16 - $13.11 $69,992 - $90,314	-6,889 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$9.04 - $11.86 $22,654 - $29,721	-2,506 Reduced 26.67%	6,889 $77,000
Q4 2020 Jan 20, 2021	SELL	$9.05 - $12.2 $3,004 - $4,050	-332 Reduced 3.41%	9,395 $107,000
Q3 2020 Oct 19, 2020	BUY	$8.99 - $10.74 $87,445 - $104,467	9,727 New	9,727 $87,000
Q4 2018 Feb 13, 2019	SELL	$7.8 - $16.13 $74,934 - $154,960	-9,607 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $137,476 - $169,563	9,607 New	9,607 $177,000
Q1 2018 May 14, 2018	SELL	$11.13 - $13.63 $32,633 - $39,963	-2,932 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $35,653 - $42,748	2,932	2,932 $44,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History